BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Promega Corporation's New Trypsin/Lys-C Mix Enhances Proteolysis of Difficult-to-Digest Proteins


3/5/2013 11:31:54 AM

05 March 2013, Madison, WI USA: Promega Corporation announces the launch of Trypsin/Lys-C Mix, Mass Spectrometry Grade. A unique combination of Trypsin Gold and rLys-C proteases, the new mix increases peptide generation with in-solution protein digestion and works with even difficult to digest proteins.

Enhanced proteolytic activity achieved through use of Trypsin/Lys-C Mix can result in a 20-40% increase in the number of peptides generated, enabling a higher number of proteins to be identified. Trypsin/Lys-C Mix is also tolerant to Trypsin-inhibiting contaminants, enabling researchers to generate mass spectrometry data from poor-quality sample material such as FFPE sections.

Many proteins are resistant to trypsin due to tight conformation, and although protein denaturation enables proteolysis, trypsin is inactive under these conditions. Promega’s Trypsin/Lys-C Mix overcomes this barrier as it remains active even under strong denaturing conditions, enabling digestion of even proteolytically resistant proteins.

For more information about Promega’s Trypsin/Lys-C Mix please visit: www.promega.com/tryplys

Promega has been a market leader in providing Trypsin and alternative proteases for mass spectrometry analysis for over 15 years.

For a high resolution image please contact Zyme Communications

Contacts:

Penny Patterson

Sr. Director, Communications

Promega Corporation

Phone: (608) 274-4330

E-mail: penny.patterson@promega.com

Katie Odgaard

Zyme Communications Ltd

Tel: +44 (0) 7787 502 947

Email: katie.odgaard@zymecommunications.com

Skype: kodgaard

www.zymecommunications.com

About Promega

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,500 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 15 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES